BroadcastMed Celebrates 20 Years of Quality Healthcare Broadcasting
Research and Markets: Global Endoscopy Equipment Market Forecasts & Opportunities 2014-2018: Endoscopes, Visualization Systems & Application
R&D investments and a narrowed focus have widened the firm's competitive advantages.
Mallinckrodt's lack of scale and weak branded business keep it from earning a moat.
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.
Health-care stocks are on a tear as demand slowly returns.
Morningstar StockInvestor editor Matt Coffina discusses recent additions to the Wide Moat Focus Index.
Our top managers remain cautious, focusing more on relative valuation and increasing their willingness to book gains in the face of a rising (but potentially overvalued) market.
With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.